ENDONOVO THERAPEUTICS, INC. Deferred Compensation Liability, Current
ENDONOVO THERAPEUTICS, INC. (ENDV) had Deferred Compensation Liability, Current of $4.55 million as of 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationLiabilityCurrent · last filed 2023-05-22
- 2023-03-31: Deferred Compensation Liability, Current $4.55M.
- 2022-12-31: Deferred Compensation Liability, Current $4.44M.
- 2022-09-30: Deferred Compensation Liability, Current $4.36M.
- 2022-06-30: Deferred Compensation Liability, Current $4.21M.
| Period end | Deferred Compensation Liability, Current |
|---|---|
| 2023-03-31 | $4.55M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $4.44M 10-Q · filed 2023-05-22 |
| 2022-09-30 | $4.36M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $4.21M 10-Q · filed 2022-08-22 |
| 2022-03-31 | $4.04M 10-Q · filed 2022-05-19 |
| 2021-12-31 | $3.89M 10-K · filed 2023-04-17 |
| 2021-09-30 | $3.97M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $3.74M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $3.49M 10-Q · filed 2021-05-24 |
| 2020-12-31 | $3.38M 10-K · filed 2022-04-14 |
| 2020-09-30 | $3.15M 10-Q · filed 2020-11-19 |
| 2020-06-30 | $2.82M 10-Q · filed 2020-08-19 |
| 2020-03-31 | $2.64M 10-Q · filed 2020-06-12 |
| 2019-12-31 | $2.43M 10-K · filed 2021-04-13 |
| 2019-09-30 | $2.39M 10-Q · filed 2019-11-19 |
| 2019-06-30 | $2.34M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $2.28M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.25M 10-K · filed 2020-05-04 |
| 2017-12-31 | $2.08M 10-K · filed 2019-04-15 |
| 2014-12-31 | $1.52M 10-K · filed 2015-06-15 |